Foxo Technologies INC 8-K filings

FOXO Technologies Inc. has approved a 1-for-1.99 reverse stock split, effective July 27, 2025, to ensure compliance with NYSE American's minimum stock price requirement.

FOXO Technologies Inc.'s behavioral health subsidiary, Myrtle Recovery Centers, Inc., has been approved to receive Scott County Opioid Abatement Funds for a second consecutive year, starting July 1, 2025, to provide care for uninsured patients.

FOXO Technologies Inc. has designated a new Series E Cumulative Redeemable Secured Preferred Stock to be used as acquisition currency and for capital raising, aiming to fund growth without diluting common stockholders.

FOXO Technologies Inc. announced that its majority stockholder approved several share issuances related to preferred stock and convertible note conversions, along with a 1:1.99 reverse stock split, primarily to ensure compliance with NYSE American LLC Company Guide rules.

FOXO Technologies Inc. announced that its critical access hospital, Big South Fork Medical Center in Oneida, Tennessee, has commenced offering new inpatient and outpatient wound care services, anticipating increased net revenues.

FOXO Technologies Inc. announced the formation of a new wholly-owned subsidiary for healthcare acquisitions, plans for a new preferred stock to fund these acquisitions, and the appointment of Seamus Lagan as Interim CFO following the unexpected passing of Martin Ward.

FOXO Technologies Inc. announced a new Securities Purchase Agreement for $1.5 million in net proceeds from Series A Preferred Stock, highlighting a substantial improvement in stockholders' equity and ongoing efforts to increase revenue.

FOXO Technologies Inc. announces that its Big South Fork Medical Center in Tennessee will begin offering wound care services on both an inpatient and outpatient basis starting June 2, 2025.

Myrtle Recovery Centers, a subsidiary of FOXO Technologies, has reached significant patient care milestones since commencing operations in August 2023.

FOXO Technologies Inc. has finalized a 1-for-10 reverse stock split, effective April 28, 2025, aimed at consolidating its outstanding common stock.

FOXO Technologies Inc. announces a 1-for-10 reverse stock split effective April 28, 2025, aimed at increasing the price per share of its Class A Common Stock.

FOXO Technologies Inc. announces a 1-for-10 reverse stock split, effective April 28, 2025, to comply with NYSE American listing requirements.

FOXO Technologies Inc. announces the filing of its Annual Report on Form 10-K for the year ended December 31, 2024, which includes an audit opinion with an explanatory paragraph regarding the company's ability to continue as a going concern.

FOXO Technologies Inc. filed an amendment to its Certificate of Incorporation on March 31, 2025, removing the automatic conversion feature of its Series D Preferred Stock to treat the issued shares as equity.

FOXO Technologies Inc. announces a non-binding agreement to acquire Vector Biosource Inc., a biospecimen sourcing provider, for a combination of preferred stock and earnout payments.

FOXO Technologies Inc. amends its Series D Preferred Stock designation to remove an automatic conversion right, allowing the company to treat the issued shares as equity.

FOXO Technologies Inc. announces that its subsidiary, Myrtle Recovery Centers, Inc., has reached stabilization with a consistent occupancy rate of 75% or greater since the beginning of 2025 and is participating in the ETAADAC conference.

FOXO Technologies Inc. announces stockholder approval for potential issuances of common stock exceeding 20% to comply with NYSE American regulations.

FOXO Technologies Inc. has announced a non-binding agreement to acquire two assisted living facilities in Florida for a total consideration of $60 million.

FOXO Technologies Inc. provides an update on recent accomplishments, including debt restructuring and acquisitions, and outlines its business strategy for 2025, focusing on growing healthcare businesses and monetizing its epigenetics division.

FOXO Technologies has successfully converted $3.45 million in senior promissory notes into Series B Preferred Stock, effectively eliminating this debt.

FOXO Technologies Inc. shareholders have approved the conversion of senior promissory notes into preferred stock and the subsequent issuance of common stock.

FOXO Technologies Inc. successfully obtained shareholder approval for proposals related to the conversion of Series A Preferred Stock and potential change of control at a special meeting held on January 17, 2025.

FOXO Technologies Inc. has announced the details for its Special Meeting of Shareholders to be held virtually on January 17, 2025.

FOXO Technologies Inc. will hold a special shareholder meeting on January 17, 2025, to seek approval for proposals related to the issuance of shares and potential change of control.

FOXO Technologies Inc. has amended its Certificate of Incorporation to include a beneficial ownership limitation for its Series A Preferred Stock.

FOXO Technologies Inc. held its Annual General Meeting on December 31, 2024, where all proposals, including the election of directors and ratification of the accounting firm, were approved by stockholders.

FOXO Technologies Inc. has agreed to issue shares of Series D Cumulative Redeemable Preferred Stock to Mitchell Silberberg & Knupp LLP to settle a $1.5 million debt for legal services, also granting registration rights for the underlying common shares.

FOXO Technologies Inc. will hold its 2024 Annual General Meeting virtually on December 31, 2024, to approve directors and auditors.

FOXO Technologies has been notified by NYSE Regulation that it has regained compliance with all continued listing standards, resolving previous deficiencies.